C1FSL5 AF NFT

tRNA (guanine-N(1)-)-methyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifzbcibzdl7qe2xspiu4iwvl5ek2ukvay3rw667zu5juxirgzdexi/metadata.json
IPFS of structure file: 
bafybeig6jvo5qcgp47npovdxdu2el2pozuwqmete4hp73xah5pgt3klx34/AF-C1FSL5-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x83D41D67fBE58b08eAFC0b0e700399Bf4326f413
First NFT owner address (bech32): 
genesis1s02p6elmuk9s36hupv88qquehapjdaqnrmjk30
Current NFT ID #474668 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
474668
Accession (UniProt):
C1FSL5
Name::
tRNA (guanine-N(1)-)-methyltransferase
Experimental Method:
Predicted structure
Sequence source:
CLOSTRIDIUM BOTULINUM (STRAIN KYOTO / TYPE A2)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT C1FSL5 research and analysis (ICN3D with VR)

FASTA sequences

>sp|C1FSL5|TRMD_CLOBJ tRNA (guanine-N(1)-)-methyltransferase OS=Clostridium botulinum (strain Kyoto / Type A2) OX=536232 GN=trmD PE=3 SV=1 MRIDVLTLFPEMFSIFNHSIIGKAIEKEILKINTVNIRDYTIDKHKKVDDYPYGGGAGMVMAAQPIVDAIKTVKKENKGKVIFLGPKGKTFNQNLAKELAKEEELIFLCGHYEGIDERAYEYIDMEISLGDFVLTGGEMACIPIVDSICRLVDGVLKSSESYEDESFYNGLLEYPQYTRPAIYEGKSVPEVLLSGHHENIKKWRKAKSLIITNKVRPDLFKKYKLTEEDKKILKDFNKKL